Literature DB >> 7712016

Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor.

Y Endo1, M Nakamura, Y Nitta, K Kumagai.   

Abstract

1. Our previous work has shown that injection into mice of lipopolysaccharide (LPS) and the cytokines interleukin 1 (IL-1) and tumour necrosis factor (TNF) induces histidine decarboxylase (HDC), the enzyme forming histamine, in various tissues such as liver, lung, spleen and bone marrow, but not in the blood. The induction of HDC also occurs in nude mice and mast cell-deficient mice. On the other hand, haematopoietic cytokines such as IL-3, granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF) only induce HDC in the haematopoietic organs, i.e. bone marrow and spleen. In the present study, the effect of macrophage depletion on the induction of HDC was examined. 2. On day 1 after a single intravenous injection of a macrophage depletor (liposomes encapsulating dichloromethylene diphosphonate, which is toxic when ingested into macrophages), macrophages were almost completely depleted in the liver and reduced by about 50% in the spleen and bone marrow, but not significantly affected in the lung. On day 3, the degrees of the depletion were similar to those of day 1. In the spleen, macrophages were depleted in the red pulp, and there was a structural destruction. 3. In macrophage-depleted mice, the induction of HDC by LPS, IL-1 alpha or TNF-alpha was not impaired in the liver, and was potentiated in the lung and bone marrow. The induction of HDC was decreased only in the spleen at day 3. 4. HDC was not induced by LPS in the spleen of the adult rat, which is correspondingly inactive in haematopoiesis.5 These results indicate that the major cells in which HDC activity is induced in response to LPS, IL-1 and TNF are not circulating granulocytes, circulating monocytes, T cells derived from thymus, mast cells or phagocytic macrophages. Based on these results, we discuss the possibility that the major cells in which HDC was induced in non-haematopoietic and haematopoietic organs were endothelial cells and haematopoietic precursor cells respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712016      PMCID: PMC1510148          DOI: 10.1111/j.1476-5381.1995.tb14924.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell.

Authors:  J W Byron
Journal:  Agents Actions       Date:  1977-07

2.  Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor.

Authors:  Y Furutani; M Notake; M Yamayoshi; J Yamagishi; H Nomura; M Ohue; R Furuta; T Fukui; M Yamada; S Nakamura
Journal:  Nucleic Acids Res       Date:  1985-08-26       Impact factor: 16.971

Review 3.  Significance of histamine formation and release in the development of endotoxic shock: proof of current concepts by randomized controlled studies in rats.

Authors:  E Neugebauer; W Lorenz; T Beckurts; D Maroske; H Merte
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

Review 4.  The endogenous mediator of endotoxic shock.

Authors:  B Beutler; A Cerami
Journal:  Clin Res       Date:  1987-04

5.  A simple method for the determination of polyamines and histamine and its application to the assay of ornithine and histidine decarboxylase activities.

Authors:  Y Endo
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 6.  The influence of histamine on immune and inflammatory responses.

Authors:  D J Beer; S M Matloff; R E Rocklin
Journal:  Adv Immunol       Date:  1984       Impact factor: 3.543

7.  Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice.

Authors:  Y Endo
Journal:  Biochem Pharmacol       Date:  1982-04-15       Impact factor: 5.858

8.  Induction of histidine decarboxylase in mouse tissues by mitogens in vivo.

Authors:  Y Endo
Journal:  Biochem Pharmacol       Date:  1983-12-15       Impact factor: 5.858

9.  Macrophages can produce factors capable of inducing histidine decarboxylase, a histamine-forming enzyme, in vivo in the liver, spleen, and lung of mice.

Authors:  Y Endo; R Suzuki; K Kumagai
Journal:  Cell Immunol       Date:  1986-01       Impact factor: 4.868

10.  Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture.

Authors:  S Hirsch; J M Austyn; S Gordon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  8 in total

1.  Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver.

Authors:  Daniel Stone; Ying Liu; Dmitry Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

2.  Induction of histidine decarboxylase in skeletal muscle in mice by electrical stimulation, prolonged walking and interleukin-1.

Authors:  Y Endo; T Tabata; H Kuroda; T Tadano; K Matsushima; M Watanabe
Journal:  J Physiol       Date:  1998-06-01       Impact factor: 5.182

3.  Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice.

Authors:  M Nakamura; T Ando; M Abe; K Kumagai; Y Endo
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.

Authors:  Y Endo; M Shibazaki; K Yamaguchi; K Kai; S Sugawara; H Takada; H Kikuchi; K Kumagai
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate.

Authors:  Y Endo; M Shibazaki; K Yamaguchi; M Nakamura; H Kosugi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Involvement of interleukin-1 in the inflammatory actions of aminobisphosphonates in mice.

Authors:  K Yamaguchi; K Motegi; Y Iwakura; Y Endo
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Histamine forming capacity (HFC) and its modulation by H3 receptor ligands in a model of bronchial hyper-responsiveness.

Authors:  M C Allen; P Graham; G Morris
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

8.  Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.

Authors:  Tzu-Kai Lin; Mao-Qiang Man; Juan-Luis Santiago; Kyungho Park; Truus Roelandt; Yuko Oda; Melanie Hupe; Debra Crumrine; Hae-Jin Lee; Maria Gschwandtner; Jacob P Thyssen; Carles Trullas; Erwin Tschachler; Kenneth R Feingold; Peter M Elias
Journal:  J Invest Dermatol       Date:  2012-09-27       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.